We are live on
!
Find out more
CBIO
Crescent Biopharma
CBIO
CBIO
32 hedge funds and large institutions have $114M invested in Crescent Biopharma in 2014 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 8 increasing their positions, 9 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
11% less funds holding
Funds holding: 36 → 32 (-4)
11% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 9
27% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 15
50% less capital invested
Capital invested by funds: $230M → $114M (-$116M)
Holders
32
Holders Change
-4
Holders Change %
-11.11%
% of All Funds
0.92%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
11
Increased
8
Reduced
9
Closed
15
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Franklin Resources
San Mateo,
California
|
+$1.77M |
| 2 |
Northern Trust
Chicago,
Illinois
|
+$432K |
| 3 |
PP
Paloma Partners
Greenwich,
Connecticut
|
+$343K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$336K |
| 5 |
MSA
Mason Street Advisors
Milwaukee,
Wisconsin
|
+$240K |
